On the subject in the title: Insulin combinations and hypoglycaemia risk Working notes rather than a conclusion.
I was wrong about insulin combinations and hypoglycaemia risk in a thread last spring and I would like to correct it publicly rather than quietly.
The error was in the units, which changed the conclusion by an order of magnitude. Setting out the corrected version, and the way I now check for that class of mistake.
This follows the opening post rather than contradicting it.
Where the insulin combinations and hypoglycaemia risk discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence with different clothes on.
Worth separating two things that the opening post runs together.
If you are new and reading this thread for the answer to insulin combinations and hypoglycaemia risk: the answer is conditional, the conditions are in the third reply, and the rest of the thread is worth skipping.
Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration is to limit it.
I am describing what is, rather than arguing for what should be.
Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose adjustment of the secretagogue and close monitoring. The combination is not contraindicated but requires active management.
That is all the detail I have. Someone else will have more.
Taking post #5 at face value and following it one step further.
The bit of insulin combinations and hypoglycaemia risk that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread will converge.
Everything in post #8 holds. The case it does not cover is the one I have.
Reporting rather than recommending, on insulin combinations and hypoglycaemia risk. What happened is above. Whether it should have is a different question and not one I am qualified to answer.
Checked the insulin combinations and hypoglycaemia risk claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower scope.
The most defensible general position in this subcategory: identify the plausible mechanism, check whether it has been studied, and where it has not, say that rather than filling the gap.
Everything in post #11 holds. The case it does not cover is the one I have.
Anticoagulant questions come up regularly and are the clearest case for professional advice rather than discussion, because the consequence of being wrong is not gradual.
Written quickly, so the reasoning may be tighter than the wording.
Narrowing post #11, because the general version has more than one answer.
Absence of an interaction study is not evidence of no interaction. A great many combinations discussed here have simply never been studied, and saying so is more useful than reasoning from mechanism alone.
Noting that the question and the thing people usually mean by it are different.
Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
Insulin combinations and hypoglycaemia risk came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
Staff rationale: Hidden by community flags. Described a research-use-only compound as approved for human use after a correction earlier in this topic (R4).
I read the earlier replies on insulin combinations and hypoglycaemia risk twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said rather than what I expected.
The corresponding entry is in the public moderation log. Hidden posts are never deleted.
The arithmetic in post #16 is right; the assumption feeding it is the part to check.
SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
On balance I think that is right, and I would not bet much on it.
I had written a reply contradicting post #16 and deleted it. Here is what survived.
A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper interaction database, and that access is the thing a forum does not have.
If this contradicts something upthread, the upthread version may well be the better one.
Insulin and sulfonylureas are the interaction that the labelling in this class flags most explicitly, because the risk is additive glucose lowering. That is a prescribing question and not a forum question.
The part I am sure of is shorter than the part I have written.
Renal or hepatic impairment changes the calculus for a lot of combinations and is the context most often missing from an interaction question here.
Old habit: I write down the expected answer before I calculate it.
Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose adjustment of the secretagogue and close monitoring. The combination is not contraindicated but requires active management.
I would put this at better than even and not much better.
Confirming post #20 from a second method, which matters more than confirming it from a second person.
Adding the boring version of insulin combinations and hypoglycaemia risk, because the interesting version keeps getting posted and the boring one is usually right.
Check the ordinary explanations, in order, and stop when one of them accounts for what you are seeing. Most of the time the second one does.
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Coming back to: Grapefruit: why this class is not the class that cares
Posting this under the heading it deserves: Grapefruit: why this class is not the class that cares Everything below is what sits behind that. I was wrong about Grapefruit in a thread last spring and I would…
|
+44 | 48 | 12k | 18mo |
|
Alcohol: what is documented and what is folklore — the long version
Alcohol: what is documented and what is folklore — the long version — setting out what I have, and where I think it stops being reliable. A narrow question about Alcohol, deliberately narrow, because the…
|
+9 | 13 | 7.3k | 6mo |
|
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs matter
Delayed gastric emptying and oral medication absorption: which drugs matter Writing it up because I had to work it out twice and would rather nobody else did. Reading back through what has been written here…
|
+63 | 74 | 11k | 1d |
|
Sulfonylureas: the interaction most worth taking seriously
Sulfonylureas: the interaction most worth taking seriously Writing it up because I had to work it out twice and would rather nobody else did. An honest uncertainty about sulfonylureas rather than a disguised…
|
+4 | 8 | 38k | 6h |
|
Delayed gastric emptying and oral medication absorption: which drugs matter — one year on
On the subject in the title: Delayed gastric emptying and oral medication absorption: which drugs matter — one year on Working notes rather than a conclusion. A follow-up question about Delayed gastric…
|
3 | 16k | 2mo |
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
When a preprint is the best available evidence and we say so — a second dataset
When a preprint is the best available evidence and we say so — a second dataset I have a specific reason for asking rather than idle curiosity, and the context is below. A preprint question rather than a…
|
+20 | 24 | 36k | 14mo |
|
Sulfonylureas: the interaction most worth taking seriously — what changed since
On the subject in the title: Sulfonylureas: the interaction most worth taking seriously — what changed since Working notes rather than a conclusion. What changes if the standard account of Sulfonylureas is…
|
+3 | 7 | 35k | 1d |
|
Follow-up: Evidence quality in the secretagogue literature: an honest assessment
On the subject in the title: Evidence quality in the secretagogue literature: an honest assessment Working notes rather than a conclusion. A follow-up question about Evidence quality that I did not know to…
|
+20 | 24 | 18k | 4mo |
|
Anaesthesia and elective surgery: the aspiration question — does this still hold?
Anaesthesia and elective surgery: the aspiration question — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Asking about Anaesthesia and…
|
+23 | 27 | 5.6k | 17mo |
|
Preprint servers and what screening they do
Preprint servers and what screening they do — setting out what I have, and where I think it stops being reliable. A preprint question rather than a question about the finding in it. The manuscript is on a…
|
+95 | 106 | 5.6k | 4mo |